Sheila Anne Doggrell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sheila Anne Doggrell has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Dsc
Senior Lecturer in Pharmacology, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, GPO 2434, QLD 4002, Brisbane, Australia
12 shared publicationsJules C Hancox
University of Bristol, School of Physiology and Pharmacology, Bristol, UK
3 shared publications- Jules C. Hancox
University of Bristol
3 shared publications Anne-Marie Christensen
2 shared publicationsJanet C Wanstall
2 shared publicationsM App Sc
Queensland University of Technology, Discipline of Medical Sciences, Faculty of Science and Technology, Brisbane, GPO 2343, QLD4002, Australia +61 7 3138 2015; +61 7 3138 1534
2 shared publications
Latest Publications
- Open Access
- 25 April 2023
- Published by Springer Nature in BMC Nursing
- Vol. 22 (1) , 1-8
Follow-up descriptive study of how proportioning marks between coursework and examination affects the performance of students in nursing
There has been little attention to how the allocation of marks affects the academic performance of students in courses. Our previous study showed that students in nursing had much lower marks in exams than coursework (tutorials and case study) in a pharmacology course. It is not known whether this applies to nursing students in other courses and/or with different types of coursework. The purpose of this study was to analyse how the allocation of marks to examination and different coursework affected the performance of students in nursing in a bioscience course. For the 379 completing students in a nursing degree undertaking a first-year first semester bioscience course, a descriptive study was undertaken of (i) the marks for the exam and two coursework components (individually undertaken laboratory skills, and a team/group project on health communication), with the marks being compared by Students t-test, (ii) any association between these marks was determined by regression line analysis, and (iii) modelling was undertaken to determine the effects of changing the allocation of marks on passing and failing rates. Students in nursing who completed a bioscience course had much lower marks in the exam than the coursework. Regression line analysis of the marks in the exam versus combined coursework showed (a) a poor line fit and (b) the correlation coefficient was moderate (r = 0.51), for the individual laboratory skills vs. exam was moderate (r = 0.49), but only weak for the group project on health communication vs. exam (r = 0.25). A high percentage of students passed the course (97%). Modelling showed that increasing the marks for the exam decreased the number of students passing the course to as few as 57%. The allocation of marks determines the percentage of students in nursing who pass courses, regardless of the type of coursework. The students in nursing in the bioscience course, who pass the course based on marks from coursework, but not the examination component, may not have the necessary knowledge to continue their program of study. Thus, requiring students in nursing to pass exams should be given further consideration.
- 25 April 2023
- Published by Springer Nature in BMC Nursing
- Vol. 22 (1) , 1-8
Open AccessFollow-up descriptive study of how proportioning marks between coursework and examination affects the performance of students in nursing
There has been little attention to how the allocation of marks affects the academic performance of students in courses. Our previous study showed that students in nursing had much lower marks in exams than coursework (tutorials and case study) in a pharmacology course. It is not known whether this applies to nursing students in other courses and/or with different types of coursework. The purpose of this study was to analyse how the allocation of marks to examination and different coursework affected the performance of students in nursing in a bioscience course. For the 379 completing students in a nursing degree undertaking a first-year first semester bioscience course, a descriptive study was undertaken of (i) the marks for the exam and two coursework components (individually undertaken laboratory skills, and a team/group project on health communication), with the marks being compared by Students t-test, (ii) any association between these marks was determined by regression line analysis, and (iii) modelling was undertaken to determine the effects of changing the allocation of marks on passing and failing rates. Students in nursing who completed a bioscience course had much lower marks in the exam than the coursework. Regression line analysis of the marks in the exam versus combined coursework showed (a) a poor line fit and (b) the correlation coefficient was moderate (r = 0.51), for the individual laboratory skills vs. exam was moderate (r = 0.49), but only weak for the group project on health communication vs. exam (r = 0.25). A high percentage of students passed the course (97%). Modelling showed that increasing the marks for the exam decreased the number of students passing the course to as few as 57%. The allocation of marks determines the percentage of students in nursing who pass courses, regardless of the type of coursework. The students in nursing in the bioscience course, who pass the course based on marks from coursework, but not the examination component, may not have the necessary knowledge to continue their program of study. Thus, requiring students in nursing to pass exams should be given further consideration.
- Open Access
- 21 April 2023
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 51 (4) , 377-388
Differences between students in various programs in a biochemistry course in lecture attendance, engagement, and academic outcomes
The positive relationship between lecture attendance and academic outcomes may be changing in the era of lecturing recordings. The objective of the study was to test this and to determine whether it varied between student cohorts. Consenting students in biochemistry from pharmacy, biomedical science, medical laboratory science, and nutrition programs, which had access to lecture recordings, signed in when attending lectures. Attendance was related to academic outcomes by regression analysis. Average attendance was low (≤19%) and declined significantly between years for most weeks. The students who attended ≥50% of lectures (≤17%) had higher marks than those that attended <50%. Overall regression analysis showed there were positive associations between most academic outcomes and lecture attendance or engagement (attendance and lecture recording access). However, these associations were weak or moderate for students in the pharmacy and biomedical science programs and were not apparent for students in the medical laboratory science and nutrition programs. In a separate survey, the most common reason for attending lectures was “I think I learn more by attending” and for not attending, was “Work commitments made it difficult to get to lectures.” The main conclusion is that students of biochemistry should be encouraged to attend lectures, as the limited evidence suggests that attendance may still be associated with better academic outcomes and that some students find them beneficial.
- 21 April 2023
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 51 (4) , 377-388
Open AccessDifferences between students in various programs in a biochemistry course in lecture attendance, engagement, and academic outcomes
The positive relationship between lecture attendance and academic outcomes may be changing in the era of lecturing recordings. The objective of the study was to test this and to determine whether it varied between student cohorts. Consenting students in biochemistry from pharmacy, biomedical science, medical laboratory science, and nutrition programs, which had access to lecture recordings, signed in when attending lectures. Attendance was related to academic outcomes by regression analysis. Average attendance was low (≤19%) and declined significantly between years for most weeks. The students who attended ≥50% of lectures (≤17%) had higher marks than those that attended <50%. Overall regression analysis showed there were positive associations between most academic outcomes and lecture attendance or engagement (attendance and lecture recording access). However, these associations were weak or moderate for students in the pharmacy and biomedical science programs and were not apparent for students in the medical laboratory science and nutrition programs. In a separate survey, the most common reason for attending lectures was “I think I learn more by attending” and for not attending, was “Work commitments made it difficult to get to lectures.” The main conclusion is that students of biochemistry should be encouraged to attend lectures, as the limited evidence suggests that attendance may still be associated with better academic outcomes and that some students find them beneficial.
- 28 December 2022
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (3) , 309-313
A new role for an old drug: acetazolamide in decompensated heart failure
Mortality from heart failure remains high. Many subjects who have been hospitalised with acute decompensated heart failure leave hospital with residual congestion, despite treatment with loop diure...
- 28 December 2022
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (3) , 309-313
A new role for an old drug: acetazolamide in decompensated heart failure
Mortality from heart failure remains high. Many subjects who have been hospitalised with acute decompensated heart failure leave hospital with residual congestion, despite treatment with loop diure...
- 2 November 2022
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 22 (11) , 1339-1343
The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?
The involvement of B-cells in multiple sclerosis has only recently emerged. Ublituximab is a monoclonal antibody that binds to the B-cell antigen CD20 with enhanced B-cell targeting.This evaluation...
- 2 November 2022
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 22 (11) , 1339-1343
The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?
The involvement of B-cells in multiple sclerosis has only recently emerged. Ublituximab is a monoclonal antibody that binds to the B-cell antigen CD20 with enhanced B-cell targeting.This evaluation...
- 5 April 2022
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 23 (7) , 769-773
Are there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)?
Anemia is common in CKD and increases the risk of developing heart disease. Although ESAs relieve the symptoms of anemia, they have adverse effects and do not reduce the adverse outcomes associated with anemia. This evaluation is of the phase 3 ASCEND clinical trials of the hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor daprodustat versus ESAs in subjects with CKD undergoing dialysis or not. Daprodustat was non-inferior to ESAs in increasing hemoglobin, and in the incidence of cardiovascular events and adverse effects. Daprodustat is effective in subjects who are hyporesponsive to ESAs, and this is one circumstance when daprodustat may be preferred to ESAs. However, to become a widely used medicine in subjects with CKD responsive to ESAs, daprodustat needs to be well tolerated, used by a high percentage of subjects over a long time, and be superior to ESAs in improving clinical outcomes. As this may not be the case, there is not a strong basis for recommending daprodustat over ESAs. The other ‘dustats’ (roxadustat, vadadustat) have also not been shown to be superior to the ESAs, and none have been approved by the FDA to date.
- 5 April 2022
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 23 (7) , 769-773
Are there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)?
Anemia is common in CKD and increases the risk of developing heart disease. Although ESAs relieve the symptoms of anemia, they have adverse effects and do not reduce the adverse outcomes associated with anemia. This evaluation is of the phase 3 ASCEND clinical trials of the hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor daprodustat versus ESAs in subjects with CKD undergoing dialysis or not. Daprodustat was non-inferior to ESAs in increasing hemoglobin, and in the incidence of cardiovascular events and adverse effects. Daprodustat is effective in subjects who are hyporesponsive to ESAs, and this is one circumstance when daprodustat may be preferred to ESAs. However, to become a widely used medicine in subjects with CKD responsive to ESAs, daprodustat needs to be well tolerated, used by a high percentage of subjects over a long time, and be superior to ESAs in improving clinical outcomes. As this may not be the case, there is not a strong basis for recommending daprodustat over ESAs. The other ‘dustats’ (roxadustat, vadadustat) have also not been shown to be superior to the ESAs, and none have been approved by the FDA to date.
- 29 December 2021
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 23 (4) , 447-451
Adding liraglutide to diet and exercise to maintain weight loss – is it worth it?
Obesity is a major risk factor for cardiovascular disease, diabetes, osteoarthritis, and some cancers. Weight loss is an obvious management for this, but a major problem is that after weight loss, ...
- 29 December 2021
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 23 (4) , 447-451
Adding liraglutide to diet and exercise to maintain weight loss – is it worth it?
Obesity is a major risk factor for cardiovascular disease, diabetes, osteoarthritis, and some cancers. Weight loss is an obvious management for this, but a major problem is that after weight loss, ...
- 1 December 2021
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 45 (4) , 651-660
Quantitative study of lecture attendance and the association between this attendance and academic outcomes for nursing and nonnursing students in an introductory pathophysiology course
Since the availability of lecture recordings, there have been limited studies of any associations between face-to-face lecture attendance and academic outcomes. The aims of the study, in an introductory pathophysiology course, where lecture recordings were available, were 1) to quantify lecture attendance and any associations between academic outcomes and lecture attendance, and 2) to determine why students do or do not attend lectures. Data were analyzed for the whole cohort before separating the nursing (∼60%) and nonnursing students. Of 288 enrolled students, 205 consented to sign the attendance register, and 139 to undertake the online survey. Lecture attendance was higher (41%) before the midsemester exam than afterwards (24%), P < 0.001, due to higher attendance by the nursing than nonnursing students. Students who attended ≥50% of lectures consistently got higher academic outcomes than those that attended P ≤ 0.05), with no association for nonnursing students. From the survey, most students who attended lectures did so because they considered they learned more by attending lectures, whereas not liking the lecture time was the most common reason for not attending lectures. In conclusion, even though students have access to lecture recordings, lecture attendance is still a determinant of academic outcomes for some students of pathophysiology.
- 1 December 2021
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 45 (4) , 651-660
Quantitative study of lecture attendance and the association between this attendance and academic outcomes for nursing and nonnursing students in an introductory pathophysiology course
Since the availability of lecture recordings, there have been limited studies of any associations between face-to-face lecture attendance and academic outcomes. The aims of the study, in an introductory pathophysiology course, where lecture recordings were available, were 1) to quantify lecture attendance and any associations between academic outcomes and lecture attendance, and 2) to determine why students do or do not attend lectures. Data were analyzed for the whole cohort before separating the nursing (∼60%) and nonnursing students. Of 288 enrolled students, 205 consented to sign the attendance register, and 139 to undertake the online survey. Lecture attendance was higher (41%) before the midsemester exam than afterwards (24%), P < 0.001, due to higher attendance by the nursing than nonnursing students. Students who attended ≥50% of lectures consistently got higher academic outcomes than those that attended P ≤ 0.05), with no association for nonnursing students. From the survey, most students who attended lectures did so because they considered they learned more by attending lectures, whereas not liking the lecture time was the most common reason for not attending lectures. In conclusion, even though students have access to lecture recordings, lecture attendance is still a determinant of academic outcomes for some students of pathophysiology.
- 29 September 2021
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 21 (11) , 1359-1362
Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
Treatments for subjects with Covid-19 are required. One approach is neutralising monoclonal antibodies. Bamlanivimab and etesevimab are monoclonal antibodies to SARS-CoV-2.This evaluation is of the...
- 29 September 2021
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 21 (11) , 1359-1362
Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
Treatments for subjects with Covid-19 are required. One approach is neutralising monoclonal antibodies. Bamlanivimab and etesevimab are monoclonal antibodies to SARS-CoV-2.This evaluation is of the...
- 8 July 2021
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 30 (8) , 797-801
Still grasping at straws: donanemab in Alzheimer’s disease
Alzheimer’s disease is the leading cause of disability and poor health, takes a huge emotional and financial burden on family caregivers, and is costly. Donanemab (LY3002813) is a new monoclonal an...
- 8 July 2021
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 30 (8) , 797-801
Still grasping at straws: donanemab in Alzheimer’s disease
Alzheimer’s disease is the leading cause of disability and poor health, takes a huge emotional and financial burden on family caregivers, and is costly. Donanemab (LY3002813) is a new monoclonal an...